NCT05954702
Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After Esophagectomy No drug interventions treatment Not Available recruiting NCT01608464
Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer treatment 2 terminated NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT06645808
PET-imaging of Two Vartumabs in Patients with Solid Tumors No drug interventions other 0 not_yet_recruiting NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT05780736
A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer No drug interventions Not Available Not Available terminated NCT04607590
Yoga Program for Improving the Quality of Life in Couples Coping With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01544790
Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy No drug interventions treatment 3 completed NCT02559687
Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180) treatment 2 completed NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. No drug interventions treatment 1 completed NCT03381651
Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma No drug interventions treatment Not Available unknown_status NCT03507998
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors treatment 1 unknown_status NCT00636298
Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy treatment 2 withdrawn NCT06009705
Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer Not Available Not Available recruiting NCT05952661
Minimally Residual of Esophageal Cancer 001 No drug interventions Not Available Not Available recruiting NCT02120911
Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma treatment 1 / 2 completed NCT05777707
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma treatment 1 / 2 recruiting NCT02355249
Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer No drug interventions treatment 3 unknown_status NCT06354218
Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age treatment 2 recruiting NCT02564263
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) treatment 3 completed NCT00642239
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma No drug interventions treatment 4 unknown_status NCT05775939
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial No drug interventions diagnostic Not Available recruiting NCT02527057
Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer No drug interventions Not Available Not Available unknown_status NCT03110926
Induction Chemotherapy for Locally Advanced Esophageal Cancer treatment 2 active_not_recruiting NCT03099382
Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer treatment 3 completed NCT00590031
Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. treatment 2 completed NCT02965976
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer supportive_care 2 completed NCT04652180
Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy . No drug interventions treatment Not Available recruiting NCT00733889
A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma treatment 2 completed NCT01366144
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction treatment 1 active_not_recruiting NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT01097304
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia prevention 2 completed NCT06494046
Defining Musical Toxicity and Its Effect on Patient Well-being No drug interventions Not Available Not Available not_yet_recruiting NCT03013712
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer No drug interventions treatment 1 / 2 unknown_status NCT06067438
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer supportive_care 2 recruiting NCT02861690
Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma treatment 2 completed NCT05996484
Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma treatment 2 not_yet_recruiting NCT01855854
Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH treatment 2 completed NCT03094351
Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy No drug interventions treatment 3 recruiting NCT04505553
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer No drug interventions supportive_care 2 active_not_recruiting NCT01034683
Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma treatment 3 unknown_status NCT03220009
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma treatment 2 withdrawn NCT06265285
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program health_services_research 2 recruiting NCT02062632
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy supportive_care 2 terminated NCT00176800
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma treatment 2 completed NCT03948100
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers No drug interventions supportive_care Not Available recruiting NCT03933449
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study treatment 3 completed NCT06549413
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer No drug interventions Not Available Not Available recruiting NCT06048913
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age treatment 1 enrolling_by_invitation NCT04517019
Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy No drug interventions supportive_care Not Available recruiting NCT01766986
Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction No drug interventions Not Available Not Available completed NCT01691625
Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer No drug interventions treatment Not Available completed NCT04147494
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues No drug interventions basic_science 0 recruiting NCT00991094
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy No drug interventions Not Available Not Available recruiting NCT05476380
Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma treatment 2 recruiting NCT06231680
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) treatment 2 recruiting NCT01262040
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive No drug interventions diagnostic Not Available completed NCT06199895
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer treatment 2 recruiting NCT05795595
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01937208
Comparable Study of Different Radiation Dose in Esophageal Carcinoma No drug interventions treatment 3 unknown_status NCT05937438
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma No drug interventions treatment 1 / 2 recruiting NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT04027543
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study） No drug interventions Not Available Not Available completed NCT02999893
A Study of APR-246 in Oesophageal Cancer treatment 1 / 2 terminated NCT03246516
Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers No drug interventions prevention Not Available active_not_recruiting NCT03835663
The Bacterial Composition of the Stomach in Reflux Disease No drug interventions Not Available Not Available active_not_recruiting NCT00220129
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus treatment 2 completed NCT03233724
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas treatment 1 / 2 terminated NCT02457650
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies treatment 1 unknown_status